A Pilot Study for Blood Based Biomarkers for Patients with Lung Cancer Receiving Radiation Therapy

This research study is currently not recruiting patients.

See other Lung Neoplasm Research Studies

A Pilot Study for Blood Based Biomarkers for Patients with Lung Cancer Receiving Radiation Therapy

Study Overview

The purpose of this study is to collect blood and tissue samples from patients with lung cancer before, during and after radiation therapy in order to identify potential biomarkers that might help us in the future to develop a blood or urine test that can be used to predict cancer reoccurrence and radiation therapy side effects for each individual patient.

Study Description

Research Study Identifier: TX6385

ClinicalTrials.gov Identifier: NCT1606191988 (IUSCC-0580)

Principal Investigator: Tim Lautenschlaeger, MD

Not Recruiting

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

Last Name

First name is mandatory

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Last Updated: Jan 29, 2019

Recruitment Status: Closed